Human Growth Hormone Market Size Worth USD 14.51 Billion by 2034 | CAGR: 8.4%

The human growth hormone market size is expected to reach USD 14.51 Billion by 2034, according to a new study by Polaris Market Research. The report “Human Growth Hormone Market Size, Share, Trends, Industry Analysis Report: By Type (Long-acting, Short-acting & Intermediate-acting), By Route of Administration, By Age, By Disease, By Distribution Channel, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human growth hormone is a protein hormone produced by the pituitary gland that stimulates growth, cell reproduction, and regeneration in humans. It plays a crucial role in childhood growth and continues to regulate body composition, muscle and bone growth, and metabolism in adults.

Biosimilars which are cheaper, similar versions of original biologic drugs, are becoming more popular in the hGH market. Companies like Sandoz and Teva are introducing biosimilar versions at lower prices as patents for branded hGH products expire. These drugs provide the same therapeutic benefits but at a reduced cost, making treatment more accessible to a larger population. The entry of biosimilars further increases competition, driving innovation and reducing healthcare costs. Governments and insurers are encouraging their use, especially in developing countries, which opens new opportunities for market growth and patient access.

Bottom of Form

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/human-growth-hormone-market/request-for-sample

Modern drug delivery systems are making human growth hormone therapy easier and more comfortable for patients. Traditional hGH treatments often required daily injections, which could be painful and inconvenient. However, new technologies such as long-acting formulations, auto-injectors, and needle-free devices are improving the patient experience. These advancements increase patient compliance, especially in children who may fear daily injections. Improved delivery methods further reduce the frequency of doses needed, making therapy more manageable. More patients are willing to begin and stay on treatment as these user-friendly solutions become widely available, boosting market growth.

Human Growth Hormone Market Report Highlights

• The long-acting segment is expected to grow at a CAGR of 9.3% during the forecast period, driven by its ability to enhance patient adherence and convenience.
• In 2024, the online pharmacies segment captured a significant revenue share of 14.66%, as e-pharmacies are rapidly becoming a popular channel for distributing human growth hormone, especially following the pandemic.
• North America accounted for 39.18% of the global human growth hormone market revenue in 2024, supported by advanced healthcare infrastructure, high awareness of growth disorders, and substantial spending on specialty drugs.
• The Asia Pacific market is projected to grow at a CAGR of 9.8% over the forecast period, driven by increasing awareness of hormone disorders and improvements in healthcare infrastructure.
• The global key market players are AnkeBio Co., Ltd; Ascendis Pharma; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Ferring Pharmaceuticals; Merck KGaA; Novo Nordisk A/S; Pfizer Inc; Sandoz Inc.; Teva Pharmaceuticals USA, Inc.

Polaris market research has segmented the human growth hormone market report based on type, route of administration, age, disease, distribution channel, and region:

By Type (Revenue - USD Billion, 2020–2034)

• Long-acting
• Short-acting & Intermediate-acting

By Route of Administration (Revenue - USD Billion, 2020–2034)

• Oral
• Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

By Age (Revenue - USD Billion, 2020–2034)

• Pediatric
• Adult

By Disease (Revenue - USD Billion, 2020–2034)

• Growth Hormone Deficiency
  • Pediatric GHD
  • Adult GHD
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Others

By Distribution Channel (Revenue - USD Billion, 2020–2034)

• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA